To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Isoproscaline (or 4-(i)-propyl-3,5-dimethoxyphenethylamine) is an analogue of mescaline. It is closely related to proscaline and was first synthesized by David E. Nichols. It produces hallucinogenic, psychedelic, and entheogenic effects.
Additional recommended knowledge
Isoproscaline is in a class of compounds commonly known as phenethylamines, and the full chemical name is 2-(4-isopropoxy-3,5-dimethoxyphenyl)ethanamine.
Little is known about the psychopharmacological effects of isoproscaline. Shulgin lists a psychedelic dosage as being 40-80 mg, with effects lasting 12-18 hours.
The mechanism that produces the hallucinogenic and entheogenic effects of isoproscaline is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines.
The toxicity of isoproscaline is not known.
Isoproscaline is unscheduled and unregulated in the United States, however because of its close similarity in structure and effects to mescaline, possession and sale of isoproscaline may be subject to prosecution under the Federal Analog Act.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Isoproscaline". A list of authors is available in Wikipedia.|